PPE Request
个人防护装备要求
基本信息
- 批准号:10582490
- 负责人:
- 金额:$ 143.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-02 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:COVID-19 Prevention NetworkCOVID-19 riskCOVID-19 vaccineClinicDiseaseEnrollmentEnvironmentFaceGogglesGovernmentParticipantPhysical ExaminationPreventionProceduresSARS-CoV-2 infectionScheduleVisitWorkcommunity transmissionhigh risknasal swabpersonal protective equipmentprogression riskscreeningsurgical masktransmission processvaccine trialventilationvolunteer
项目摘要
Project Abstract
On-going US government sponsored COVID-19 vaccine trials require screening, enrolling, and following over
150,000 volunteer study participants over 24-36 months. The trial participants are selected based on their risk
of COVID-19 infection, with trial participants coming from settings with high rates of community transmission,
groups with higher risk of progression to symptomatic disease, or both. Study staff working on COVID-19
vaccine trials interact with trial participants during scheduled trial assessments and unscheduled sick visits,
which includes high risk procedures such as nasal swabbing and performing physical examinations in often
poorly ventilated environments. As a result, a regular supply of personal protective equipment (PPE), including
surgical masks, face shields or goggles, gowns, and disposable gloves, is critical for their own protection and
for prevention of transmission within the clinic. This project will provide on-going PPE support to COVID-19
Prevention Network (CoVPN) trials across three continents, completing work anticipated through 2023.
1
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lawrence Corey其他文献
Lawrence Corey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lawrence Corey', 18)}}的其他基金
Personal Protective Equipment for Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies
用于 COVID-19 相关疫苗和治疗临床试验和临床研究资源的个人防护装备
- 批准号:
10252679 - 财政年份:2020
- 资助金额:
$ 143.87万 - 项目类别:
HVTN 405/HPTN 1901 Characterizing SARS-CoV-2-specific immunity in convalescent individuals
HVTN 405/HPTN 1901 表征恢复期个体的 SARS-CoV-2 特异性免疫力
- 批准号:
10167020 - 财政年份:2020
- 资助金额:
$ 143.87万 - 项目类别:
Personal Protective Equipment for Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies
用于 COVID-19 相关疫苗和治疗临床试验和临床研究资源的个人防护装备
- 批准号:
10225246 - 财政年份:2020
- 资助金额:
$ 143.87万 - 项目类别:
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
利用组织驻留记忆 T 细胞进行疱疹病毒感染的免疫治疗
- 批准号:
9926222 - 财政年份:2018
- 资助金额:
$ 143.87万 - 项目类别:
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
利用组织驻留记忆 T 细胞进行疱疹病毒感染的免疫治疗
- 批准号:
10409768 - 财政年份:2018
- 资助金额:
$ 143.87万 - 项目类别:
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
利用组织驻留记忆 T 细胞进行疱疹病毒感染的免疫治疗
- 批准号:
10593354 - 财政年份:2018
- 资助金额:
$ 143.87万 - 项目类别:
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
利用组织驻留记忆 T 细胞进行疱疹病毒感染的免疫治疗
- 批准号:
10160756 - 财政年份:2018
- 资助金额:
$ 143.87万 - 项目类别:
相似海外基金
Knockoff statistics-driven interpretable deep learning models for uncovering potential biomarkers for COVID-19 risk prediction
山寨统计驱动的可解释深度学习模型,用于发现潜在的 COVID-19 风险预测生物标志物
- 批准号:
468265 - 财政年份:2022
- 资助金额:
$ 143.87万 - 项目类别:
Fellowship Programs
The re-examination of covid-19 risk communication from the perspective of leadership
从领导力角度重新审视covid-19风险沟通
- 批准号:
22K03029 - 财政年份:2022
- 资助金额:
$ 143.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids
AICORE-kids:针对儿童的人工智能 COVID-19 风险评估
- 批准号:
10320488 - 财政年份:2021
- 资助金额:
$ 143.87万 - 项目类别:
AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids
AICORE-kids:针对儿童的人工智能 COVID-19 风险评估
- 批准号:
10733689 - 财政年份:2021
- 资助金额:
$ 143.87万 - 项目类别:
RAPID: Real-time Forecasting of COVID-19 risk in the USA
RAPID:美国 COVID-19 风险的实时预测
- 批准号:
2108526 - 财政年份:2021
- 资助金额:
$ 143.87万 - 项目类别:
Standard Grant
ESG RoboFactory Covid-19 Risk Robots
ESG RoboFactory Covid-19 风险机器人
- 批准号:
10024664 - 财政年份:2021
- 资助金额:
$ 143.87万 - 项目类别:
Collaborative R&D
How do perceptions of Covid-19 risk influence health decisions in pregnancy? A mixed methods study
对 Covid-19 风险的看法如何影响怀孕期间的健康决策?
- 批准号:
460341 - 财政年份:2021
- 资助金额:
$ 143.87万 - 项目类别:
Operating Grants
AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids
AICORE-kids:针对儿童的人工智能 COVID-19 风险评估
- 批准号:
10272787 - 财政年份:2021
- 资助金额:
$ 143.87万 - 项目类别:
AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids
AICORE-kids:针对儿童的人工智能 COVID-19 风险评估
- 批准号:
10847803 - 财政年份:2021
- 资助金额:
$ 143.87万 - 项目类别:
RAPID: CORPUS: An Edge Intelligence-Assisted Multi-Granularity COVID-19 Risk Predication and Update System
RAPID:CORPUS:边缘智能辅助的多粒度 COVID-19 风险预测和更新系统
- 批准号:
2027251 - 财政年份:2020
- 资助金额:
$ 143.87万 - 项目类别:
Standard Grant